Bosentan therapy for chronic thromboembolic pulmonary hypertension. A national open label study assessing the effect of Bosentan on haemodynamics, exercise capacity, quality of life, safety and tolerability in patients with chronic thromboembolic pulmonary hypertension (BOCTEPH-Study)
Options
Date of Publication
2007
Publication Type
Article
Language(s)
en
Contributor(s)
Ulrich, S | |
Speich, R | |
Domenighetti, G | |
Aubert, JD | |
Rochat, T | |
Huber, L | |
Treder, U | |
Fischler, M |
Additional Credits
Series
Swiss medical weekly
Publisher
EMH Schweizerischer Ärzteverlag
ISSN
1424-7860
Access(Rights)
metadata.only